AAAAAA

   
Results: 1-18 |
Results: 18
Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screening
Authors: Knight, GJ Palomaki, GE Neveux, LM Haddow, JE Lambert-Messerlian, GM
Citation: Gj. Knight et al., Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screening, J MED SCREE, 8(1), 2001, pp. 2-7
An evaluation of analytic coals for assays of drugs - A College of American Pathologists Therapeutic Drug Monitoring Survey study
Authors: Steele, BW Wang, E Palomaki, GE Klee, GG Elin, RJ Soldin, SJ Witte, DL
Citation: Bw. Steele et al., An evaluation of analytic coals for assays of drugs - A College of American Pathologists Therapeutic Drug Monitoring Survey study, ARCH PATH L, 125(6), 2001, pp. 729-735
Maternal thyroid deficiency and pregnancy complications: implications for population screening
Authors: Allan, WC Haddow, JE Palomaki, GE Williams, JR Mitchell, ML Hermos, RJ Faix, JD Klein, RZ
Citation: Wc. Allan et al., Maternal thyroid deficiency and pregnancy complications: implications for population screening, J MED SCREE, 7(3), 2000, pp. 127-130
Reference distributions for the positive acute phase proteins, alpha(1)-acid glycoprotein (Orosomucoid), alpha(1)-antitrypsin, and haptoglobin: A comparison of a large cohort to the world's literature
Authors: Ritchie, RF Palomaki, GE Neveux, LM Navolotskaia, O
Citation: Rf. Ritchie et al., Reference distributions for the positive acute phase proteins, alpha(1)-acid glycoprotein (Orosomucoid), alpha(1)-antitrypsin, and haptoglobin: A comparison of a large cohort to the world's literature, J CL LAB AN, 14(6), 2000, pp. 265-270
Reference distributions for the positive acute phase serum proteins, alpha(1)-acid glycoprotein (orosomucoid), alpha(1)-antitrypsin, and haptoglobin:A practical, simple, and clinically relevant approach in a large cohort
Authors: Ritchie, RF Palomaki, GE Neveux, LM Navolotskaia, O Ledue, TB Craig, WY
Citation: Rf. Ritchie et al., Reference distributions for the positive acute phase serum proteins, alpha(1)-acid glycoprotein (orosomucoid), alpha(1)-antitrypsin, and haptoglobin:A practical, simple, and clinically relevant approach in a large cohort, J CL LAB AN, 14(6), 2000, pp. 284-292
Second trimester levels of maternal serum inhibin A in pregnancies affected by fetal neural tube defects
Authors: Lambert-Messerlian, GM Palomaki, GE Canick, JA
Citation: Gm. Lambert-messerlian et al., Second trimester levels of maternal serum inhibin A in pregnancies affected by fetal neural tube defects, PRENAT DIAG, 20(8), 2000, pp. 680-682
First trimester biochemical screening for Down syndrome: free beta hCG versus intact hCG - Response to Hallahan et al.
Authors: Haddow, JE Palomaki, GE Knight, GJ
Citation: Je. Haddow et al., First trimester biochemical screening for Down syndrome: free beta hCG versus intact hCG - Response to Hallahan et al., PRENAT DIAG, 20(10), 2000, pp. 790-791
Prevalence of GAD autoantibodies in women with gestational diabetes - A retrospective analysis
Authors: Mitchell, ML Hermos, RJ Larson, CA Palomaki, GE Haddow, JE
Citation: Ml. Mitchell et al., Prevalence of GAD autoantibodies in women with gestational diabetes - A retrospective analysis, DIABET CARE, 23(11), 2000, pp. 1705-1706
Issues in implementing prenatal screening for cystic fibrosis: Results of a working conference (vol 1, pg 129, 1999)
Authors: Haddow, JE Bradley, LA Palomaki, GE Doherty, RA Bernhardt, BA Brock, DJH Cheuvront, B Cunningham, GC Donnenfeld, AE Erickson, JL Erlick, HA Ferrie, RM FitzSimmons, SC Greene, MF Grody, WW Haddow, PK Harris, H Holmes, LB Howell, RR Katz, M Klinger, KW Kloza, EM LeFevre, ML Little, S Loeben, G McGovern, M Pyeritz, RE Rowley, PT Saiki, RK Short, MP Tabone, J Wald, NJ Wilker, NL Witt, DR
Citation: Je. Haddow et al., Issues in implementing prenatal screening for cystic fibrosis: Results of a working conference (vol 1, pg 129, 1999), GENET MED, 1(5), 1999, pp. 193-193
Issues in implementing prenatal screening for cystic fibrosis: Results of a working conference
Authors: Haddow, JE Bradley, LA Palomaki, GE Doherty, RA Bernhardt, BA Brock, DJH Cheuvront, B Cunningham, GC Donnenfeld, AE Erickson, JL Erlich, HA Ferrie, RM FitzSimmons, SC Greene, MF Grody, WW Haddow, PK Harris, H Holmes, LB Howell, RR Katz, M Klinger, KW Kloza, EM LeFevre, ML Little, S Loeben, G McGovern, M Pyeritz, RE Rowley, PT Saiki, RK Short, MP Tabone, J Wald, NJ Wilker, NL Witt, DR
Citation: Je. Haddow et al., Issues in implementing prenatal screening for cystic fibrosis: Results of a working conference, GENET MED, 1(4), 1999, pp. 129-135
Issues in implementing prenatal screening for cystic fibrosis: results of a working conference
Authors: Haddow, JE Bradley, LA Palomaki, GE Doherty, RA
Citation: Je. Haddow et al., Issues in implementing prenatal screening for cystic fibrosis: results of a working conference, J MED SCREE, 6(2), 1999, pp. 60-66
Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: A practical, simple and clinically relevant approach in a large cohort
Authors: Ritchie, RF Palomaki, GE Neveux, LM Navolotskaia, O Ledue, TB Craig, WY
Citation: Rf. Ritchie et al., Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: A practical, simple and clinically relevant approach in a large cohort, J CL LAB AN, 13(6), 1999, pp. 273-279
Reference distributions for the negative acute-phase proteins, albumin, transferrin, and transthyretin: A comparison of a large cohort to the world'sliterature
Authors: Ritchie, RF Palomaki, GE Neveux, LM Navolotskaia, O
Citation: Rf. Ritchie et al., Reference distributions for the negative acute-phase proteins, albumin, transferrin, and transthyretin: A comparison of a large cohort to the world'sliterature, J CL LAB AN, 13(6), 1999, pp. 280-286
Second-trimester maternal serum analyte levels associated with fetal trisomy 13
Authors: Saller, DN Canick, JA Blitzer, MG Palomaki, GE Schwartz, S Blakemore, KJ Haddow, JE
Citation: Dn. Saller et al., Second-trimester maternal serum analyte levels associated with fetal trisomy 13, PRENAT DIAG, 19(9), 1999, pp. 813-816
Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz (RSH) syndrome fetuses
Authors: Bradley, LA Palomaki, GE Knight, GJ Haddow, JE Opitz, JM Irons, M Kelley, RI Tint, GS
Citation: La. Bradley et al., Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz (RSH) syndrome fetuses, AM J MED G, 82(4), 1999, pp. 355-358
Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child
Authors: Haddow, JE Palomaki, GE Allan, WC Williams, JR Knight, GJ Gagnon, J O'Heir, CE Mitchell, ML Hermos, RJ Waisbren, SE Faix, JD Klein, RZ
Citation: Je. Haddow et al., Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child, N ENG J MED, 341(8), 1999, pp. 549-555
Prenatal screening for open neural-tube defects in Maine
Authors: Palomaki, GE Williams, JR Haddow, JE
Citation: Ge. Palomaki et al., Prenatal screening for open neural-tube defects in Maine, N ENG J MED, 340(13), 1999, pp. 1049-1050
Age-related prevalence of Down syndrome
Authors: Palomaki, GE Haddow, JE
Citation: Ge. Palomaki et Je. Haddow, Age-related prevalence of Down syndrome, AM J OBST G, 180(6), 1999, pp. 1597-1597
Risultati: 1-18 |